Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>Croma Security Solutions Group 72.50p £10.0m (CSSG.L) The service-focused security solutions Company reports the completion of the acquisition of Southern Security Services Limited (SSS), for £0.55m which is to be funded from existing resources.</li>
<li>For FY December 2025, SSS generated revenues of £1.04m and EBITDA of £0.13m and had a net asset value of £0.43m.</li>
<li>Founded in 1983 the specialist locksmith business based in Poole, Dorset is primary focused on commercial customers with key clients such as local authorities and healthcare-sector operators. </li>
</ul>


Croma Security Solutions Group 72.50p £10.0m (CSSG.L) The service-focused security solutions Company reports the completion of the acquisition of Southern Security Services Limited (SSS), for £0.55m which is to be funded from existing resources.
For FY December 2025, SSS generated revenues of £1.04m and EBITDA of £0.13m and had a net asset value of £0.43m.
Founded in 1983 the specialist locksmith business based in Poole, Dorset is primary focused on commercial customers with key clients such as local authorities and healthcare-sector operators. 


Zentra Group PLC - Hybridan Small Cap Feast: 16 March 2026

<ul>
<li>AOTI Inc 32.50p £39.35m (AOTI.L) The medical technology Company focused on delivering outcomes-based care at home updates on trading for the FY December 2025.</li>
<li>Revenue is expected to increase 14% to $66.5m which is inline as is EBITDA at c. $5.9m.</li>
<li>Net debt increased to c.$6.5m with funding in place to support its ongoing working capital needs. </li>
</ul>


AOTI Inc 32.50p £39.35m (AOTI.L) The medical technology Company focused on delivering outcomes-based care at home updates on trading for the FY December 2025.
Revenue is expected to increase 14% to $66.5m which is inline as is EBITDA at c. $5.9m.
Net debt increased to c.$6.5m with funding in place to support its ongoing working capital needs. 


Victoria PLC - Hybridan Small Cap Feast: 23 February 2026

<ul>
<li>80 Mile 0.98p £48.56m (80M.L) The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved the proposed acquisition by Pelican Acquisition Corporation (PELI), the NASDAQ-listed special purpose acquisition company, of Greenland Exploration Limited, and March GL, and, subject only to shareholder approval, is now set to start trading on NASDAQ as Greenland Energy Company.</li>
<li>Under the terms of 80 Mile's definitive joint venture agreement, PELI is entitled to earn up to a 70% working interest in Jameson by funding 100% of the costs associated with up to two exploration wells, each to a minimum depth of approximately 3,500 metres.</li>
<li>80 Mile will retain a 30% interest in Jameson through its wholly owned subsidiary White Flame Energy A/S.</li>
</ul>


80 Mile 0.98p £48.56m (80M.L) The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved the proposed acquisition by Pelican Acquisition Corporation (PELI), the NASDAQ-listed special purpose acquisition company, of Greenland Exploration Limited, and March GL, and, subject only to shareholder approval, is now set to start trading on NASDAQ as Greenland Energy Company.
Under the terms of 80 Mile's definitive joint venture agreement, PELI is entitled to earn up to a 70% working interest in Jameson by funding 100% of the costs associated with up to two exploration wells, each to a minimum depth of approximately 3,500 metres.
80 Mile will retain a 30% interest in Jameson through its wholly owned subsidiary White Flame Energy A/S.


Hybridan Small Cap Feast: 19 February 2026

<ul>
<li>Arecor Therapeutics 80.00p £29.26m (AREC.L) The biopharmaceutical Company focused on drug development and enhanced delivery in diabetes and other cardiometabolic diseases provided a business update for the 12 months ended 31 December 2025.</li>
<li>The Company continued focus on two core product areas: diabetes and oral delivery of peptides.</li>
<li>A codevelopment deal was signed in September 2025 with Sequel Med Tech to combine Arecor's ultra-concentrated, ultra-rapid-acting (500U/mL) insulin AT278 with Sequel's twist Automated Insulin Delivery (AID) system. </li>
</ul>


Arecor Therapeutics 80.00p £29.26m (AREC.L) The biopharmaceutical Company focused on drug development and enhanced delivery in diabetes and other cardiometabolic diseases provided a business update for the 12 months ended 31 December 2025.
The Company continued focus on two core product areas: diabetes and oral delivery of peptides.
A codevelopment deal was signed in September 2025 with Sequel Med Tech to combine Arecor's ultra-concentrated, ultra-rapid-acting (500U/mL) insulin AT278 with Sequel's twist Automated Insulin Delivery (AID) system. 


Hybridan Small Cap Feast: 9 February 2026

<ul>
<li>Agronomics 5.85p £60m (ANIC.L) The Isle of Man-based Investment firm announced an additional investment of AU$3m in its portfolio company, All G Co Holdings Pty Limited, an Australian biotech specialising in precision fermentation of human and bovine milk proteins, notably lactoferrin.</li>
<li>This technology enables the production of lactoferrin without the use of animals, supporting advancements in nutrition, sustainability, and health.</li>
<li>All G's lactoferrin is cost-effective and environmentally sustainable, suitable for applications in infant and clinical nutrition, functional foods, skincare, and animal nutrition. </li>
</ul>


Agronomics 5.85p £60m (ANIC.L) The Isle of Man-based Investment firm announced an additional investment of AU$3m in its portfolio company, All G Co Holdings Pty Limited, an Australian biotech specialising in precision fermentation of human and bovine milk proteins, notably lactoferrin.
This technology enables the production of lactoferrin without the use of animals, supporting advancements in nutrition, sustainability, and health.
All G's lactoferrin is cost-effective and environmentally sustainable, suitable for applications in infant and clinical nutrition, functional foods, skincare, and animal nutrition. 


Hybridan Small Cap Feast: 15 January 2026

United Kingdom

Panther Metals is a mineral exploration company focused on the discovery of commercially viable mineral deposits and tailings reprocessing opportunities, primarily targeting established mining jurisdictions in Canada and Australia. The company invests in or acquires companies or projects within the natural resources sector, with a focus on base, precious, and energy metals. It aims to generate cash flow from its Winston tailings project to fund high-impact exploration activities across its Canadian portfolio, which includes projects like Obonga (Wishbone and Awkward), Dotted Lake, and Winston. The company was incorporated in 2013 and is based in Hitchin, Hertfordshire, United Kingdom, with a registered address in Douglas, Isle of Man.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Panther Metals (PALM LN)

Zentra Group PLC - Hybridan Small Cap Feast: 16 March 2026

Founded in 1983 the specialist locksmith business based in Poole, Dorset is primary focused on commercial customers with key clients such as local...

Hybridan

Victoria PLC - Hybridan Small Cap Feast: 23 February 2026

AOTI Inc 32.50p £39.35m (AOTI.L) The medical technology Company focused on delivering outcomes-based care at home updates on trading for the FY...

Hybridan

Hybridan Small Cap Feast: 19 February 2026

The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved...

Hybridan

Hybridan Small Cap Feast: 9 February 2026

The biopharmaceutical Company focused on drug development and enhanced delivery in diabetes and other cardiometabolic diseases provided a business...

Hybridan

Hybridan Small Cap Feast: 15 January 2026

All G's lactoferrin is cost-effective and environmentally sustainable, suitable for applications in infant and clinical nutrition, functional...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)